August 18, 2026 12:58 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
BJP reshuffles top organisation seven months after Nitin Nabin's elevation | West Bengal STF arrests suspected aide of ISI 'agent' Rana Rauf in Kolkata | ‘Very hopeful’: Indian envoy Dinesh Trivedi breaks silence on PM Tarique Rahman’s proposed India visit | Shehzad Poonawalla doubles down on BJP exit, urges party to accept resignation | Tarapith tragedy: Seven pilgrims killed as hotel goes up in flames before dawn | Bengal STF nabs suspected aide of ISI 'agent' Rana Rauf in Kolkata | After SC rebuke, BCI chief apologises to NALSAR students over enrolment freeze row | Independence Day: PM Modi’s big youth pitch— AI training, free coaching amid exam row and job concerns | ‘Shakti Ki Saptadhara’: Modi reveals 7 pillars to power India’s next leap in his I-Day speech from Red Fort | West Bengal STF arrests 3 more suspected Pakistani spies in Cooch Behar

GlaxoSmithKline records 11% growth for Q2

| | Nov 06, 2014, at 04:31 am
New Delhi, Nov 5 (IBNS): GlaxoSmithKline Consumer Healthcare Limited on Wednesday declared its financial results for the second quarter ended September 30, 2014.
The company's net sales were reported at Rs 1075 crores, which recorded a growth of 11% over 2013 with PAT at Rs. 160 crores growing by 9% for the same period and PBT at Rs 245 crores growing by 10%.
 
Commenting on the results, Zubair Ahmed, Managing Director, GlaxoSmithKline Consumer Healthcare Limited said, “We are delighted to have delivered consistent growth as the category leader. The consumer sentiments are showing early signs of recovery and our brands are well poised to help consumers do more, feel better and live longer. Our relentless focus on science, innovation and customer, remains our key differentiator and helps us to stay ahead in the category."
 
"We continue to improve consumer’s experience with new products like the re-launched Horlicks with proven health benefits, ‘instantization’ and new positioning, highlighting its daily nutritional relevance. We also remain focused on our access strategy to ensure that our products are within the easy reach of our large consumer base,” Ahmed said.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.